What is the address of Dr. Maarten Pauwelyn, cardioloog?

The registered office of Dr. Maarten Pauwelyn, cardioloog is located at Lostraat(PEL) 23, 3212 Lubbeek.

Is Dr. Maarten Pauwelyn, cardioloog still active?

Yes. According to the CBE (17 September 2026) Dr. Maarten Pauwelyn, cardioloog is active, legal situation “Normale toestand”, started on 15 July 2022.

Is Dr. Maarten Pauwelyn, cardioloog registered on Peppol?

Yes, Dr. Maarten Pauwelyn, cardioloog is registered on the Peppol network with ID 0208:0788663349.

What is the enterprise number of Dr. Maarten Pauwelyn, cardioloog?

The enterprise number of Dr. Maarten Pauwelyn, cardioloog is BE0788663349.

When was Dr. Maarten Pauwelyn, cardioloog founded?

Dr. Maarten Pauwelyn, cardioloog was founded on 15 July 2022.

Who are the directors of Dr. Maarten Pauwelyn, cardioloog?

According to the 2025 annual accounts, the directors of Dr. Maarten Pauwelyn, cardioloog are: Maarten Pauwelyn.

Is Dr. Maarten Pauwelyn, cardioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 July 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Maarten Pauwelyn, cardioloog make in 2025?

Dr. Maarten Pauwelyn, cardioloog posted a profit after taxes of € 172,901 in financial year 2025.

What is the revenue of Dr. Maarten Pauwelyn, cardioloog?

As a small company, Dr. Maarten Pauwelyn, cardioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 229,016.

Dr. Maarten Pauwelyn, cardioloog (Private Limited)

Dossier Dr. Maarten Pauwelyn, cardioloog, printed on 17 September 2026 from databakkes.be/en/0788663349/dr-maarten-pauwelyn-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Maarten Pauwelyn, cardioloog from Lubbeek, company number BE0788663349, closed financial year 2025 with a result of € 172,901 after tax. For that financial year Dr. Maarten Pauwelyn, cardioloog recorded a gross margin of € 229,016 and equity of € 176,901. Compared with financial year 2024, the result moved from € 69,557 to € 172,901. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Growing

€ 176,901

▲ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 172,901

▲ 149% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 146,704

▲ 68% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 106,518 paid out

62 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 512

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 14,877

▼ 54% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 83

▲ 138% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 25,969

▼ 8% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 9,009 Gross margin 2022: € 9,009 First fiscal year in the series	€ 38,214 Gross margin 2023: € 38,214 ▲ € 29,205 vs 2022 (€ 9,009) Favourable step	€ 88,677 Gross margin 2024: € 88,677 ▲ 132% vs 2023 (€ 38,214) Favourable step	€ 229,016 Gross margin 2025: € 229,016 ▲ 158% vs 2024 (€ 88,677) Favourable step	▲ 158%
Profit after taxes	€ 7,093 Profit after taxes 2022: € 7,093 First fiscal year in the series	€ 29,868 Profit after taxes 2023: € 29,868 ▲ € 22,776 vs 2022 (€ 7,093) Favourable step	€ 69,557 Profit after taxes 2024: € 69,557 ▲ 133% vs 2023 (€ 29,868) Favourable step	€ 172,901 Profit after taxes 2025: € 172,901 ▲ 149% vs 2024 (€ 69,557) Favourable step	▲ 149%
Equity	€ 11,093 Equity 2022: € 11,093 First fiscal year in the series	€ 40,961 Equity 2023: € 40,961 ▲ 269% vs 2022 (€ 11,093) Favourable step	€ 110,518 Equity 2024: € 110,518 ▲ 170% vs 2023 (€ 40,961) Favourable step	€ 176,901 Equity 2025: € 176,901 ▲ 60% vs 2024 (€ 110,518) Favourable step	▲ 60%
Total debts	€ 7,362 Total debts 2022: € 7,362 First fiscal year in the series	€ 11,188 Total debts 2023: € 11,188 ▲ 52% vs 2022 (€ 7,362) Unfavourable step	€ 60,601 Total debts 2024: € 60,601 ▲ € 49,413 vs 2023 (€ 11,188) Unfavourable step	€ 41,935 Total debts 2025: € 41,935 ▼ 31% vs 2024 (€ 60,601) Favourable step	▼ 31%
Cash	€ 11,954 Cash 2022: € 11,954 First fiscal year in the series	€ 39,599 Cash 2023: € 39,599 ▲ 231% vs 2022 (€ 11,954) Favourable step	€ 87,105 Cash 2024: € 87,105 ▲ 120% vs 2023 (€ 39,599) Favourable step	€ 146,704 Cash 2025: € 146,704 ▲ 68% vs 2024 (€ 87,105) Favourable step	▲ 68%
Retained profit	€ 7,093 Retained profit 2022: € 7,093 First fiscal year in the series	€ 36,961 Retained profit 2023: € 36,961 ▲ € 29,868 vs 2022 (€ 7,093) Favourable step	€ 106,518 Retained profit 2024: € 106,518 ▲ 188% vs 2023 (€ 36,961) Favourable step	€ 172,901 Retained profit 2025: € 172,901 ▲ 62% vs 2024 (€ 106,518) Favourable step	▲ 62%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 106,518 Dividend 2025: € 106,518 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 32,175 Bank debt 2024: € 32,175 Unchanged (€ 0) Unfavourable step	€ 14,877 Bank debt 2025: € 14,877 ▼ 54% vs 2024 (€ 32,175) Favourable step	▼ 54%
Balance sheet total	€ 18,455 Balance sheet total 2022: € 18,455 First fiscal year in the series	€ 52,150 Balance sheet total 2023: € 52,150 ▲ 183% vs 2022 (€ 18,455) Unchanged	€ 171,119 Balance sheet total 2024: € 171,119 ▲ 228% vs 2023 (€ 52,150) Unchanged	€ 218,836 Balance sheet total 2025: € 218,836 ▲ 28% vs 2024 (€ 171,119) Unchanged	▲ 28%

Key figures of Dr. Maarten Pauwelyn, cardioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Maarten Pauwelyn, cardioloog?

What happened at Dr. Maarten Pauwelyn, cardioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 172,901 (▲ 149% vs 2024). Source: NBB ↗
Jul 15, 2022 New establishment in Lubbeek. KBO
Jul 15, 2022 Start of the company according to the CBE. KBO

In short

From € 7,093 profit in 2022 to € 172,901 profit in 2025.

Paid € 79,434 in corporate taxes since 2022.

Best year ever: 2025, with € 172,901 profit.

Paid out € 106,518 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Maarten Pauwelyn, cardioloog? We notify you, reason included.

Follow Dr. Maarten Pauwelyn, cardioloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Maarten Pauwelyn

Dr. Maarten Pauwelyn, cardioloog

Behind Dr. Maarten Pauwelyn, cardioloog is Maarten Pauwelyn.

See the full network in the app

Directors

According to the 2025 annual accounts

Maarten Pauwelyn

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Lostraat(PEL) 23

3212 Lubbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0788.663.349
VAT number: BE 0788.663.349
Registered office: Lostraat(PEL) 23, 3212 Lubbeek
Names & denominations: Dr. Maarten Pauwelyn, cardioloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 July 2022
Peppol: Active · Active since 15 Dec 2024

View on CBE Public ↗ Annual accounts (NBB) ↗